Immunoprotein is a protein type with
immunological activity that provides immunity against substances or
pathogenic organisms. These proteins are used as analytes for different
disease diagnostic assays such as CLIA, ELISA, radioimmunoassay (RIA),
and immunoturbidity assay. Immunoprotein testing products are
continuously fueled with innovative technologies, expanding the
boundaries of the immunoprotein market. The innovations lead to widening
of scope for product applications in various fields such as infectious
disease testing, allergy testing, drug abuse testing, and the most
prominent being oncology. Extensive research in the field of oncology
has resulted in various biomarkers being profiled, which are specific to
a particular type of cancer.
Report Overview @ https://www.transparencymarketresearch.com/immunoprotein-market.html
Increase in demand for quick and accurate
disease diagnosis and rise in incidence of infectious and chronic
diseases are the major factors that are likely to boost the growth of
the immunoprotein market during the forecast period. Prevalence of
diseases such as hepatitis, malaria, typhoid, HIV, tuberculosis, and
cancer is a great concern for many countries. Majority of these diseases
have high prevalence rate in underdeveloped economies; hence, demand
for low cost but effective diagnostic tests is high. Diagnosis of these
diseases in early stage may help in controlling infections and prevent
mortalities. Immunoprotein diagnostic kits provide the best option for
carrying out accurate and rapid diagnosis of the diseases. Although
these tests are expensive as compared to routine microbiology assays,
they provide faster and better results. However, the high cost of
immunoprotein products restrains the growth of the market. In addition,
low health care expenditure in underdeveloped countries and increase in
awareness about medical services have led patients to seek
cost-effective alternatives for diagnosis. These factors have been the
major restraining forces for the growth of the immunoprotein market in
developing and underdeveloped economies.
The global immunoprotein market has been
segmented based on assay type, immunoprotein type, application, and
geography. In terms of assay type, the market has been categorized into
chemiluminescence assay, enzyme based immunoassay, immunofluorescence
assay, immunoprotein electrophoresis, immunoturbidity assay, and
radioimmunoassay (RIA). Based on the immunoprotein type, the market has
been segmented into complement system proteins diagnostic tests,
C-reactive protein (CRP) tests, free light chain tests, immunoglobulin
diagnostic tests, prealbumin tests, and haptoglobin tests. Based on
application, the market has been categorized into allergy testing,
endocrine testing, autoimmune disease testing, infectious disease
testing, oncology testing, and toxicology testing.
Geographically, the immunoprotein market
is distributed over North America, Latin America, Europe, Asia Pacific,
and Middle East & Africa. North America dominated the global market
for immunoprotein products due to high awareness among people along with
rapid increase in demand for technologically advanced immunoprotein
products. The U.S. is a major contributor of the immunoprotein market
with high adoption rate of technology advanced assay systems. North
America holds a substantially large market share of the global market,
which is followed by Europe. Prevalence of chronic diseases along with
increase in demand for immunoprotein products from developed countries
such as the U.K., Germany, and France is a major factor that has helped
Europe retain its position in the global market. In the Asia Pacific
region, increase in demand for immunoprotein products from countries
such as India, China, and Japan is expected to boost the immunoprotein
market in the next few years. In addition, increased incidences of
infectious diseases and growing awareness about diagnostic testing for
various diseases are key factors driving the Asia Pacific market.
However, affordability and lack of availability for innovative
immunoprotein products are the restraining factors of the immunoprotein
market in developing and undeveloped regions such as Middle East &
Africa and Latin America. Despite of this, market in these regions is
expected a slow growth with contribution from developing countries such
as Brazil and South Africa. Latin American countries such as Mexico and
Brazil are expected to have considerable potential for driving the
immunoprotein market growth due to evolving medical structure and
increase in awareness about diagnostic testing.
The major players operating in this
market include Abbott Laboratories, Inc., Abcam plc, DiaSorin S.p.A.,
Enzo Life Sciences, Inc., FUJIREBIO Diagnostics, Inc., Omega Diagnostics
Group PLC, Roche Holding AG, Siemens AG, The Binding Site Group Ltd.,
and Thermo Fisher Scientific, Inc.
Great Article it its really informative and innovative keep us posted with new updates. its was really valuable. thanks a lot.
ReplyDeleteelectromagnetic pulse therapy